🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07100197
Starting soon Not applicable

EEG-TMS Intervening Against Postoperative Delirium

NCT07100197 · tracked via the Priya Life Science China tracker
Sponsor
RenJi Hospital
Phase
Not applicable
Started
2025-07-27
Last updated
2025-08-03

Condition(s) studied

Postoperative Delirium

Investigational drug(s) / intervention(s)

continuous Theta-burst stimulationSham

continuous Theta-burst stimulation: Treatment parameters: each cTBS session consists of 50 Hz triplets of pulses delivered at 5 Hz for 40 s, totaling 600 pulses, and every set simulation includes 3 sessions. Electrodes are attached to designated head regions (right dorsolateral prefrontal cortex).

Sham: the treatment mode was with sham coil.

Study summary

Postoperative delirium is common in elderly surgical patients and is associated with complications and prolonged hospitalisation. The aim of the RECOVER study is to assess the efficacy of electroencephalo graph (EEG)-transcranial magnetic stimulation (TMS) treatment for the management of postoperative delirium.

Eligibility

Sex
ALL
Min age
60 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Age ≥60 years; 2. Scheduled for non-cardiac surgery; 3. Positive assessment for delirium via the CAM-ICU or 3D-CAM after surgery. Exclusion Criteria: 1. Chronic use of antipsychotic medications; 2. Receipt of antipsychotic drugs prior to enrollment; 3. Permanently incapacitated patients (lacking decision-making capacity); 4. Inability to undergo delirium assessment (e.g., due to language barriers, deafness, blindness, aphasia, or coma); 5. Treatment withdrawal or brain death; 6. Known pregnancy or lactation; 7. Inability to obtain informed consent per national regulations; 8. Patients under compulsory hospitalization (involuntary commitment) by regulatory authorities; 9. Alcohol withdrawal delirium (delirium tremens); 10. Contraindications to transcranial magnetic stimulation (TMS); 11. Acute infectious diseases.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Renji hosipical, Shanghai Jiao Tong University School of Medicine Shanghai Shanghai Municipality

More RenJi Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07100197 on ClinicalTrials.gov ↗ ← All trials in China